Background Bronchodilators are commonly used as maintenance and rescue therapy in
patients with COPD. We aimed to examine the prescribing patterns of bronchodilators in …

Sustained bronchodilation using inhaled medications in moderate to severe chronic
obstructive pulmonary disease (COPD) grades 2 and 3 (Global Initiative for Chronic …

Bronchodilators remain the mainstay of chronic obstruc-tive pulmonary disease (COPD)
management and are recommended for the treatment of symptomatic patients at all stages …

Long acting inhaled bronchodilators-beta agonists and anti-cholinergic--can improve
symptoms, enhance quality of life, increase exercise ability, and reduce exacerbation rates …

The incidence of chronic obstructive pulmonary disease (COPD) is rising in the United
States, and the disease represents a significant source of morbidity and mortality. Primary …

BACKGROUND: Bronchial variability in COPD patients may be a phenotypic feature
associated with clinical characteristics and differential treatment response. We analyzed …

Background Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder
characterized by usually progressive development of airflow obstruction that is not fully …

In steroid resistant chronic obstructive pulmonary disease (COPD) we assessed the effect of
qid domiciliary nebulized fenoterol (F) 1.25 mg and ipratropium (I) 0.5 mg for three weeks in …

Introduction Long-acting bronchodilators are the therapy with the best evidence for treating
stable chronic obstructive pulmonary disease (COPD). Long-acting combinations of β2 …

Background: This study compared real-world patient-reported outcomes (PROs) measured
by the Clinical COPD Questionnaire (CCQ), the London Chest Activities of Daily Living …